After 22 minutes of trading, the OMXS30 index was up 0.78 percent to 2,534.37. During the day, the index has moved within the range of 0.65 percent at its lowest and 0.83 percent at its highest.
The broad OMXSPI was up 0.91 percent.
Share price | Price change | Commentary |
Q-Linea | 99,1% | Writes first commercial contract in the US |
Irlab | 7,5% | All patients in phase 2b study have undergone final follow-up visit |
Arjo | 5,9% | Announces change of CEO and releases preliminary figures |
Mycronic | 4,8% | Handelsbanken raises to Buy (Hold) in the short term, Market Perform (Underperform) in the long term |
Sagax | 4,3% | Carnegie raises to buy from hold, lowers target price to SEK 250 from SEK 275 |
Sinch | 3,8% | Morgan Stanley raises to equal weight from underweight, target price SEK 20.50 |
Fabege | 2,3% | Nordea raises to hold from sell, Kempen raises to neutral (sell) and SHB reiterates buy |
Epiroc | 2,2% | Pareto raises to buy from hold, reiterates target price SEK 235, ABG also raises to buy |
Bioarctic | 1,6% | FDA has received application from partner Eisai for Leqembi subcutaneous maintenance treatment |
Atrium Ljungberg | 1,7% | Carnegie raises to hold from sell, lowers target price to SEK 200 from SEK 210 |
Swedbank | 0,3% | Arctic lowers to hold from buy, target price SEK 250 |
SLP | -0,3% | Kempen lowers to neutral from buy, target price SEK 42 |
NCAB | -2,1% | Pareto Securities downgrades to hold from buy, reiterates target price SEK 69 |